Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natalizumab for postpartum MS relapses
NCT03046251Phase 4Completed
- Sponsor
- University at Buffalo
- Start
- Aug 2015
- Primary completion
- Dec 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of natalizumab in multiple sclerosis (MS), sponsored by University at Buffalo. Started Aug 2015; status: completed.
02
Drugs
natalizumab
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT03046251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03046251.